| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |